122 related articles for article (PubMed ID: 9704186)
21. Late detection of neuroblastoma in a patient with prolonged cerebellar ataxia without opsoclonus.
Wolff M; Schöning M; Niemann G; Krägeloh-Mann I
Neuropediatrics; 2001 Apr; 32(2):101-3. PubMed ID: 11414640
[TBL] [Abstract][Full Text] [Related]
22. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.
Fisher B; Dignam J; Mamounas EP; Costantino JP; Wickerham DL; Redmond C; Wolmark N; Dimitrov NV; Bowman DM; Glass AG; Atkins JN; Abramson N; Sutherland CM; Aron BS; Margolese RG
J Clin Oncol; 1996 Jul; 14(7):1982-92. PubMed ID: 8683228
[TBL] [Abstract][Full Text] [Related]
23. Paraneoplastic opsomyoclonus, cerebellar ataxia and encephalopathy associated with anti-Purkinje cell antibodies.
Honnorat J; Trillet M; Antoine JC; Aguera M; Dalmau J; Graus F
J Neurol; 1997 May; 244(5):333-5. PubMed ID: 9178161
[No Abstract] [Full Text] [Related]
24. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
25. Ethmoid sinus leiomyosarcoma after cyclophosphamide treatment.
Reich DS; Palmer CA; Peters GE
Otolaryngol Head Neck Surg; 1995 Oct; 113(4):495-8. PubMed ID: 7567030
[No Abstract] [Full Text] [Related]
26. [Sequencing of chemotherapy and radiotherapy following breast-preserving treatment of breast carcinoma].
Sauer R; Martus P
Strahlenther Onkol; 1996 Sep; 172(9):516-7. PubMed ID: 8928060
[No Abstract] [Full Text] [Related]
27. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
[TBL] [Abstract][Full Text] [Related]
28. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
29. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma.
Greenlee JE; Brashear HR
Ann Neurol; 1983 Dec; 14(6):609-13. PubMed ID: 6360029
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: the Scottish trial. Scottish Cancer Trials Breast Group and ICRF Breast Unit, Guy's Hospital, London.
Lancet; 1993 May; 341(8856):1293-8. PubMed ID: 8098446
[TBL] [Abstract][Full Text] [Related]
31. Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume.
Hetzel DJ; Stanhope CR; O'Neill BP; Lennon VA
Mayo Clin Proc; 1990 Dec; 65(12):1558-63. PubMed ID: 2255217
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous radiochemotherapy for recurrent and metastatic breast carcinoma: evaluation of two treatment concepts.
Plasswilm L; Seegenschmiedt MH; Ganssauge F; Sauer R
Am J Clin Oncol; 1996 Aug; 19(4):403-7. PubMed ID: 8677915
[TBL] [Abstract][Full Text] [Related]
33. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.
Levine MN; Bramwell VH; Pritchard KI; Norris BD; Shepherd LE; Abu-Zahra H; Findlay B; Warr D; Bowman D; Myles J; Arnold A; Vandenberg T; MacKenzie R; Robert J; Ottaway J; Burnell M; Williams CK; Tu D
J Clin Oncol; 1998 Aug; 16(8):2651-8. PubMed ID: 9704715
[TBL] [Abstract][Full Text] [Related]
34. [Ablative hormone therapy and chemotherapy of metastatic breast cancer].
Kasch R; Gerber B; Blaschke U
Zentralbl Gynakol; 1989; 111(23):1584-7. PubMed ID: 2560303
[TBL] [Abstract][Full Text] [Related]
35. The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy.
Pinder SE; Murray S; Ellis IO; Trihia H; Elston CW; Gelber RD; Goldhirsch A; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Golouh R; Rudenstam CM; Castiglione-Gertsch M; Gusterson BA
Cancer; 1998 Oct; 83(8):1529-39. PubMed ID: 9781946
[TBL] [Abstract][Full Text] [Related]
36. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
Fisher B; Dignam J; Wolmark N; DeCillis A; Emir B; Wickerham DL; Bryant J; Dimitrov NV; Abramson N; Atkins JN; Shibata H; Deschenes L; Margolese RG
J Natl Cancer Inst; 1997 Nov; 89(22):1673-82. PubMed ID: 9390536
[TBL] [Abstract][Full Text] [Related]
37. Surgical adjuvant chemotherapy for breast cancer: a comparison of CMF and CAF regimens.
Babar AM
J Pak Med Assoc; 1991 Dec; 41(12):293-6. PubMed ID: 1824559
[TBL] [Abstract][Full Text] [Related]
38. Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration.
Cunningham J; Graus F; Anderson N; Posner JB
Neurology; 1986 Sep; 36(9):1163-8. PubMed ID: 3528917
[TBL] [Abstract][Full Text] [Related]
39. [A case of elderly metastatic breast cancer with a complete response to treatment with capecitabine and cyclophosphamide].
Iida S; Furukawa K; Yokoyama T; Yanagihara K; Iwasaki R; Noguchi T; Tsuchiya S; Sugisaki Y; Naito Z; Tajiri T
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1697-700. PubMed ID: 17940394
[TBL] [Abstract][Full Text] [Related]
40. Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5.
Levine MN; Pritchard KI; Bramwell VH; Shepherd LE; Tu D; Paul N;
J Clin Oncol; 2005 Aug; 23(22):5166-70. PubMed ID: 16051958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
